Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Abstract Case Approximately 3%‐25% of cases of endometrial carcinoma (EC) or atypical endometrial hyperplasia (AH) occur in women aged <40 years and conservative treatment with high‐dose medroxyprogesterone acetate (MPA) is administered to women who wish to preserve their fertility. Here is repor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Toshiya Matsuzaki, Takeshi Iwasa, Takako Kawakita, Yuri Yamamoto, Akiko Abe, Aki Hayashi, Kiyohito Yano, Masato Nishimura, Akira Kuwahara, Minoru Irahara
Format: Artigo
Idioma:Inglês
Publicat: Wiley 2018-07-01
Col·lecció:Reproductive Medicine and Biology
Matèries:
assisted reproductive technology
atypical endometrial hyperplasia
conservative treatment
endometrial carcinoma
medroxyprogesterone acetate
Accés en línia:https://doi.org/10.1002/rmb2.12209
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars